medi-cal glp-1 coverage Ozempic will no longer be covered by after drugs cut from California's 2025–26 health budget Designing fiscally viable coverage of
Description
They are RARE

Because more than 60% of the dementia patients are women
Hospitals play a critical role in initiating advanced GLP-1 therapies, monitoring treatment outcomes, and managing complex metabolic disorders

Novo Nordisk, which owns the patent for Ozempic, now has a market cap bigger than its home country Denmarks gross domestic product

Want more of the latest from us
Data sources included the National Prescription Register (medication exposures), Medical Birth Register (pregnancy outcomes), National Patient Register (diagnoses), Educational Register (socioeconomic status), and Central Persons Register (demographics)
